Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
04/1995
04/26/1995EP0649839A1 Isoquinolinone-, phthalazinone-, quinazolinone- and benzotriazolinone derivatives, their preparation and their use as anti-thrombotics
04/26/1995EP0649838A1 N-phenylalkyl/phenoxyalkyl-azetidine/pyrrozidinel piperidine/hexahydroazepine derivatives as antiarrhythmic agents
04/26/1995EP0649654A1 Use of a combination of an ACE-inhibitor with a calcium antagonist in the treatment of proteinuria
04/26/1995EP0649650A1 Bioadhesive pharmaceutical composition for controlled release of drugs
04/26/1995EP0649602A2 Process for making soluble beet fibre
04/26/1995EP0649432A1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors
04/26/1995EP0649425A1 Pyridino-, pyrrolidino- and azepino-substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agents
04/26/1995EP0649424A1 Dioxcyclobutene derivatives as angiotensin ii antagonists
04/26/1995EP0649419A1 N-cycloalkylpiperazine derivatives, methods of obtaining them and pharmaceutical compositions containing them
04/26/1995EP0649418A1 7-(2-aminoethyl)-benzothiazolones
04/26/1995EP0649409A1 Vinyl arenas having retinoid-like activity
04/26/1995EP0649407A1 Dimeric piperidine, tetrahydropyridine and piperazine derivatives
04/26/1995EP0649303A1 Substituted arginines and substituted homoarginines and use thereof
04/26/1995EP0505468B1 Imidazole derivatives and their use as acyl coenzyme-a inhibitors
04/26/1995CN1101915A New 19-nor steroids having a phenoxyalkylsulphonamide or phenoxyalkylsulphonylurea chain in position llbeta, preparation process and intermediates, use as medicaments and pharmaceutical compositions..
04/26/1995CN1101911A Novel compounds
04/26/1995CN1101908A Angiotensin II antagonists
04/25/1995US5410064 Thromboxane A2 antagonists and inhibitors of thromboxane A2 synthase
04/25/1995US5410061 Pharmaceutical compounds
04/25/1995US5410055 Inotropic agent
04/25/1995US5410035 Administering an indigestible dextrin hypotensive agent obtained by hydrolyzing pyrodextrin with amylase
04/25/1995US5409956 A sulfonylaminoalkylindan carboxylic acid or ester for treating thrombosis, vasospasm or asthma
04/25/1995US5409950 Anticholesterol, antilipemic agents and an enzyme squalene synthase inhibitors, fungicides
04/25/1995US5409949 Methylen-oxindole derivatives compositions and tyrosine kinase inhibition therewith
04/25/1995US5409947 Treating hypertension, congestive heart failure
04/25/1995US5409945 Benzyo-fused thiazolidinyl terminated alkylamino ethylnyl alanine amino diol compounds for treatment of hypertension
04/25/1995US5409931 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
04/25/1995US5409930 Inhibits abnoramal cell proliferation; dimethoxyquinoline/ dimethylquinoline/ quinolineoxide/ and quinoxaline derivatives
04/25/1995US5409925 Oxazobicyclo terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
04/25/1995US5409924 Benzo-fused oxazobicyclo terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
04/25/1995US5409922 Renin inhibitors
04/25/1995US5409921 Renin inhibitors
04/25/1995US5409913 Oxazocinyl/thiazocinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
04/25/1995US5409910 Treating hyperlipoproteinemia and arteriosclerosis
04/25/1995US5409895 Protease inhibitory polypeptides derived from urinary trypsin inhibitor and compositions thereof
04/25/1995CA1335379C Aralkylaminoalkoxyphenyl derivatives, process of preparation and compositions containing the same
04/25/1995CA1335378C Alkylaminoalkoxyphenyl derivatives, process of preparation and compositions containing the same
04/23/1995CA2133939A1 1,2-dihydro-2-oxo-pyridines
04/23/1995CA2132883A1 1-amino-ethylindole-derivatives
04/21/1995CA2118375A1 Cyclic amine derivatives
04/20/1995WO1995010531A1 Oligopeptides derived from c-reactive protein fragments
04/20/1995WO1995010513A1 Benzothiophenes and related compounds as estrogen agonists
04/20/1995WO1995010305A1 Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes
04/20/1995WO1995010280A1 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
04/20/1995WO1995010277A1 Analgesic agent and its use
04/20/1995WO1995010271A2 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
04/20/1995CA2173243A1 Benzothiophenes and related compounds as estrogen agonists
04/20/1995CA2112871A1 Preparation process of imidazole sulfur derivatives and new intermediate products obtained
04/19/1995EP0648769A1 12-Hetero-substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizium salts and compositions and method of use thereof
04/19/1995EP0648767A1 Piperdine and piperazine derivatives which affect the C.N.S.
04/19/1995EP0648763A1 Process for the preparation of sulfur derivatives of imidazole and intermediates obtained
04/19/1995EP0648762A2 Bicyclic compounds as excitatory amino acid receptor antagonists
04/19/1995EP0648758A1 4-Arylamino-benzopyran and related compounds
04/19/1995EP0648745A1 Arylalkylamine having anticonvulsant and neuroprotective properties
04/19/1995EP0648744A1 Phenylalkanolamine derivatives as antagonists of the NMDA receptor
04/19/1995EP0648741A1 1,2,3,4-Tetrahydronaphthalene, chroman and thiochroman derivatives as antithrombotic agents
04/19/1995EP0648489A1 Arylalkylamides having neuroprotective properties
04/19/1995EP0648269A1 Novel polypeptides having nmda receptor activity, nucleic acids encoding said polypeptides and applications
04/19/1995EP0648225A1 Compositions for the inhibition of protein hormone formation and uses thereof
04/19/1995EP0648212A1 Heterocyclic compounds as pharmaceutical
04/19/1995EP0648209A1 Contrast agents for mr diagnosis
04/19/1995EP0510036B1 2-substituted 4,5-diphenyl-imidazoles
04/19/1995EP0497915B1 hPTH (1-37) FRAGMENT, ITS PRODUCTION, DRUG CONTAINING IT AND ITS USE
04/19/1995CN1101781A Pharmaceutical composition for treating cerebral thrombosis
04/19/1995CN1101644A Thiadiazinones
04/19/1995CN1028235C Pyranobenzoxadiazole derivatives
04/19/1995CN1028229C Heterocyclic compounds containing nitrogen and sulfur, pharmaceutical composition containing same and process for preparing them
04/19/1995CN1028227C Pharmacologically active 1,5-diarly-3-substituted-pyrazoles and method for synthesizing the same
04/19/1995CN1028205C Use of dihydropyridine-3,5-dihydroxy acid easter derivatives
04/19/1995CA2117852A1 Bicyclic compounds as excitatory amino acid receptor antagonists
04/18/1995US5407957 Production of docosahexaenoic acid by dinoflagellates
04/18/1995US5407956 Hypotensive agents, kidney disorders
04/18/1995US5407955 Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
04/18/1995US5407954 Arylalkoxyphenoxy-imidazoline compounds
04/18/1995US5407951 Sulphonamidocycloalkane compounds, pharmaceutical compositions containing them, and methods of use thereof
04/18/1995US5407948 Substituted mono- and bipyridylmethylpyridones
04/18/1995US5407946 Pyrrolidine compounds which are useful as thromboxane AZ-inhibitors
04/18/1995US5407942 Biphenylmethyl-substituted pyridones
04/18/1995US5407941 Platelet activating factor antagonist and antihistamine; useful for treating asthma and allergic disorders
04/18/1995US5407923 Antiinflammatory agents
04/18/1995US5407915 Human Bikunin variants as proteinase inhibitors, and medicaments containing these
04/18/1995US5407815 R-(-)-1-(5-hydroxyhexyl)-3-methyl-7-propylxanthine, a process for its preparation and pharmaceuticals containing this compound
04/16/1995CA2118097A1 Methods for inhibiting angiogenesis and angiogenic diseases
04/16/1995CA2118095A1 Methods for inhibiting smooth muscle cell proliferation and restinosis
04/16/1995CA2117853A1 Methods for lowering serum cholesterol
04/13/1995WO1995009921A1 Platelet-activating factor acetylhydrolase
04/13/1995WO1995009869A1 Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same
04/13/1995WO1995009842A1 Isoquinolinone-, phthalazinone-, quinazolinone- and benzotriazolinone derivatives, their preparation and their use as anti-thrombotics
04/13/1995WO1995009841A1 Hydroxamic acid derivatives as inhibitors of cytokine production
04/13/1995WO1995009831A1 Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation
04/13/1995WO1995009637A1 Highly sulfated maltooligosaccharides with heparin-like properties
04/13/1995WO1995009619A2 Substituted urea and isothiourea derivatives as no synthase inhibitors
04/13/1995CA2173598A1 Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same
04/13/1995CA2171465A1 Highly sulfated maltooligosaccharides with heparin-like properties
04/13/1995CA2148361A1 Isoquinolinone-, phthalazinone-, quinazolinone- and benzotriazolinone derivatives, their preparation and their use as anti-thrombotics
04/12/1995EP0647627A1 1,2-Dihydro-2-oxo-3-methylsulfonylaminomethyl-pyridines as angiotensin II antagonists
04/12/1995EP0647621A1 Aryl and heterocylic cyanoguanidine derivatives
04/12/1995EP0647266A1 D-enzyme compositions and methods of their use
04/12/1995EP0647238A1 INTERLEUKIN-1$g(b) DELETION MUTANT
04/12/1995EP0647236A1 Endothelin antagonists ii
1 ... 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 ... 1595